3 Stocks to Buy That Are Breaking Out in a Big Way

MIAMI, May 12, 2016 /PRNewswire/ --

TechStockInsider.com issues the following report:  The Dow Jones was down -217 points on May 11^th but that didn't stop these four stocks from breaking out in a big way. Technical and fundamental catalysts coupled to provide investors of these companies with massive gains. Furthermore, chart patterns and after-market trading activity hint towards momentum building rather than slowing. While the overall market takes a dip, investors should look to these four companies for profitable opportunities.

LifeClips Inc. (OTC: LCLP) has skyrocketed 77% over the last 6 trading sessions after announcing a binding letter of intent to purchase Israeli battery maker Batteryfly Energy, LTD. TechStockInsider.com has been following the company since 5/4/2016 where they alerted (LCLP) at .27 now trading at .48

LifeClips will be bringing Batterfly's flagship product, Mobeego, to the United States. Mobeego is a non-tethered, disposable, recyclable battery that provides an emergency charge to mobile phones and action cameras. The product is currently sold in countries around the world like Canada, Mexico, Australia, Malaysia, and the United Kingdom.

The Company also announced today that they have placed an initial order for its new 4k Action Camera the SoluVu™ to fulfill retail and distribution orders. SoluVu™ has several key features that competitors do not come standard with, such as; an internal gyroscope for greater image stabilization, built in motion detection for activation, and a 16 mega-pixel image camera. The SoloVu™ comes with video options of 4k, 2k, 1080 and 720.  The camera also comes with a 32GB memory card and features burst mode, time lapse & looping video modes.  SOURCE:  TechStockInsider.com

MGT Capital Investments (NYSE: MGT) has exploded after announcing John McAfee was named chief executive officer and executive chairman of the company. MGT has agreed to acquire specific technology and assets of McAfee's anti-spy software firm D-Vasive for $300,000 in cash and 23.8 million restricted shares, or 47% of the company.

MGT closed trading on May 11^th at $1.27 a share up nearly +253% in three days following the announcement. MGT traded as high as $1.46 in the after-market session and momentum has continued into the pre-market trading session with MGT breaking above $1.50.

The Company announced this morning that they have acquired a membership Interest in The Round House LLC, an Alabama-based technology incubator, offering co-working space, accelerator services and angel investment. The highlight of this announcement involves Round House's equity ownership of RecMed First Aid. RecMed was founded by a local teenager, Taylor Rosenthal. This past Monday, Taylor became the youngest person to exhibit at TechCrunch Disrupt in New York. He has been featured on numerous national media outlets in the past several days, and Taylor has stated that RecMed is being courted by some large retail and healthcare companies.

According to a report issued by CNBC, RecMed recently turned down a $30 million buyout offer.  SOURCE:  TechStockInsider.com

ChemoCentryx Inc. (NASDAQ: CCXI) has jumped more than 131% in two days after gaining licensing rights from Vifor Pharma to commercialize CCX168, a Complement 5a Receptor (C5aR) inhibitor for orphan and rare renal diseases, including anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), in Europe, Mexico, Canada, Central and South America, and South Korea. CCX168 is ready for Phase 3 study planned later this year.

The Company will receive $60 million in cash as an upfront payment and a $25 million equity investment to purchase Chemocentryx common stock at a price of $7.50 per share. The pharmaceutical company will be eligible to receive additional payments after certain regulatory and sales milestones are reached.

ChemoCentryx announced today that they have been selected for a poster presentation at the 2016 Society for Investigational Dermatology Annual Meeting on May 12, 2016, in Scottsdale, Arizona. The Company will be presenting preclinical data using a series of orally-available inhibitors of the chemokine receptor known as CCR6.  SOURCE:  TechStockInsider.com

DISCLAIMER:  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with TechStockInsider.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by TechStockInsider.com are solely those of TechStockInsider.com and are not shared by and do not reflect in any manner the views or opinions of FNM.  The companies that are discussed herein may or may not have approved the statements made in this release.  FNM is not liable for any investment decisions by its readers or subscribers FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was not compensated by any public company mentioned herein to disseminate this press release.

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Company:  FN Media Group, LLC

Contact e-mail:  [email protected]

U.S. Phone: +1(954)345-0611

URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC